SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/CB7534153BFCCE94DF174508E85F609FE024F0F854E7DDDB23C07D6C0606A782D7907091929CF59120AD488BC16D1A39>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/CB7534153BFCCE94DF174508E85F609FE024F0F854E7DDDB23C07D6C0606A782D7907091929CF59120AD488BC16D1A39
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/CB7534153BFCCE94DF174508E85F609FE024F0F854E7DDDB23C07D6C0606A782D7907091929CF59120AD488BC16D1A39
http://www.w3.org/2000/01/rdf-schema#comment
"When extended endocrine therapy with letrozole is prescribed high H/I predicts benefit from therapy and a decreased probability of late disease recurrence."
xsd:string
http://purl.uniprot.org/uniprot/#_327AEA9996C7D2704B5631D11845E99A90E38B71128360152C3C27DF22E6BC0E7AC0750C914EF49CDDC75C48D0518FAC
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/CB7534153BFCCE94DF174508E85F609FE024F0F854E7DDDB23C07D6C0606A782D7907091929CF59120AD488BC16D1A39
http://purl.uniprot.org/uniprot/Q92826
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/CB7534153BFCCE94DF174508E85F609FE024F0F854E7DDDB23C07D6C0606A782D7907091929CF59120AD488BC16D1A39
http://purl.uniprot.org/uniprot/#_Q92826-mappedCitation-23812955
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/CB7534153BFCCE94DF174508E85F609FE024F0F854E7DDDB23C07D6C0606A782D7907091929CF59120AD488BC16D1A39